Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Multiple Myeloma
Multiple Myeloma
Dissecting the Treatment Costs of Newly Diagnosed Myeloma in First 2 Years
Play Video
Multiple Myeloma
Dual-Targeted CAR T-Cell Therapy Leads to Very High Response Rates in Relapsed or Refractory Multiple Myeloma
Phoebe Starr
Phoebe Starr
Play Video
Multiple Myeloma
Elotuzumab, Lenalidomide, and Dexamethasone Combination Demonstrates High Response Rate in High-Risk Smoldering Multiple Myeloma
Chase Doyle
Chase Doyle
Play Video
Multiple Myeloma
Elotuzumab-Based Triplet Regimen Stops Progression of High-Risk Smoldering Multiple Myeloma
Wayne Kuznar
Play Video
FDA Approvals
,
Multiple Myeloma
,
Select Drug Profiles
FDA Approved Abecma, First CAR T-Cell Therapy for Multiple Myeloma
Play Video
FDA Approvals
,
Multiple Myeloma
,
Select Drug Profiles
FDA Approved Pepaxto for Relapsed or Refractory Multiple Myeloma
Play Video
FDA Approvals
,
Multiple Myeloma
,
In the News
,
Select Drug Profiles
FDA Approves Darzalex Combination for First-Line Treatment of Transplant-Eligible Patients with Multiple Myeloma
Play Video
FDA Approvals
,
Multiple Myeloma
,
Conference Highlights ASCO
FDA Approves Darzalex Faspro plus Pomalyst and Dexamethasone for Multiple Myeloma
Play Video
Multiple Myeloma
First Oral Proteasome Inhibitor Active in Myeloma
Play Video
Multiple Myeloma
FIRST Trial Shows Value for Continued Use of Lenalidomide in Transplant-Ineligible Patients with Newly Diagnosed Myeloma
Caroline Helwick
Play Video
1
2
3
4
5
Page 2 of 6
Results 11 - 20 of 52